- Open Access
- Open Peer Review
In depth analysis of risk factors for coeliac disease amongst children under 18 years Old in the Gaza strip. A cross sectional study
© Al-Raee et al.; licensee BioMed Central Ltd. 2012
- Received: 18 June 2012
- Accepted: 16 October 2012
- Published: 20 November 2012
Coeliac disease is an important clinical disorder affecting the human gastrointestinal tract leading to multiple signs and symptoms in different body organs. This disease was the subject of a cross sectional descriptive-analytic study conducted in the Gaza Strip during 2010. Objectives were oriented to identify and verify several variables and attributes affecting the prognosis of coeliac disease in the patients. Ninety five children out of 113 patients were arranged into two groups according to age from 2 to 11 years and from 12 to 18 years old. Results showed the poor interest of health professionals regarding coeliac disease in the Gaza Strip. The mean age of study population was 5.47 years for males and 8.93 years for females. The lifestyle of coeliac patients was directly proportional with better nutritional indictors. Poor recognition of the emblem illustrating gluten in foods implicates effective health awareness or promotion. The more knowledgeable patients or mothers (P = 0.036) were the more compliant. The compliance to giving gluten free foods outside home was statistically significant (P = 0.037). Similarly, cautious approach when buying foods or detergents (P = 0.011). According to BMI 74.4%, 23.4% and 3.2% of all patients were normal, underweight and overweight respectively. Albumin blood level was normal in 32.6% and low in 67.4%. Meanwhile, blood calcium level was normal in 76.8%, low in 21.1% and high in 2.1% of all patients. Conclusion: The study showed that recreation and social activities for coeliac patients are substantially missing in the Gaza Strip. Moreover, the study proved that AEI is a reliable centre for care of coeliac disease patients and conducting relevant studies. Recommendation: There is a need for thorough and continuous community and institutional mobilization regarding coeliac disease in the Gaza Strip and in Palestine.
- Ard El-Insan: AEI
- Body Mass Index: BMI
- Coeliac Diseases: CD
- Endomyseal antibodies: EMA
- Tissue Transglutaminase: TtG
Coeliac disease is an organic disease, which affects the small bowel mucosa causing disturbance of absorptive functional capacity of small intestine. The disease appears in predisposed individuals as a result of dietary exposure to gluten. The classical nature of coeliac disease is characterized by mucosa inflammation, villous atrophy, and crypt hyperplasia. Clinical and histological finding show an improvement coupled with withdrawal of gluten from the diet .
Coeliac disease is also known as Coeliacsprue, gluten-sensitive enteropathy or non tropicalsprue . The disease develops as a response to the dietary ingestion of glutens (prolamins and glutenins) of wheat and similar proteins in barley, rye and oats resulting in activation of both cell-mediated (T-cell) and humoral (B-cell) immune response in genetically susceptible persons .
Genetic predisposition is suggested by a high concordance amongst monozygotic twins approaching 70%, and in association with certain type II Human Leukocyte Antigens (HLA). Between 75% to 95% of HLA DQ2 is found in coeliac disease patients, whilst, most of the remaining patients have HLA DQ that are located in number six chromosome .
Environmental factors may also play a role in expression of coeliac disease whereas; some other factors may play a role in precipitating the symptoms. These include viral infection, high dose of gluten or early gluten challenge and pregnancy .
Coeliac patients are also specifically characterized by the presence of auto-antibodies to a connective tissue element surrounding smooth muscle called endomysium, which is highly specific for coeliac disease and known as endomyseal antibodies. Furthermore, an enzyme called tissue transglutaminase (tTG) may play a role in the pathogenesis of coeliac disease by modifying gluten peptides .
Coeliac disease appears actually in different clinical pictures and presentations.
Classical coeliac disease is gluten induced villous atrophy and presents in classical picture of intestinal malabsorption. Atypical coeliac disease might present in other different pictures such as decreased calcium levels, iron deficiency, osteoporosis, short stature, miscarriage and infertility. Silent coeliac disease might be discovered by serological screening or endoscope done to investigate other causes that are not related to the disease itself. Another form of the disease is known as latent coeliac disease characterized with delayed appearance of signs and symptoms of the disease, and it shows improvement on a gluten-free diet and appearance of normal mucosal histology .
Prevalence of coeliac disease is difficult to be estimated because of the different forms of clinical picture and variety in presentation of the disease itself, especially in patients who have mild form of the disease or those who have no apparent signs or symptoms. The highest prevalence of disease was estimated among Celtic populations and It was 1:300 to1:80 . A high prevalence of coeliac disease was estimated in European populations and the incidence was slightly high amongst girls (57%). Sub clinical or silent coeliac disease was most abundant . In the general population of developed societies it is estimated that prevalence of coeliac disease ranged mostly from 0.5% to 1%. Whilst, in the Sahara population who are African descendants of Arab-Berber and live in great African Desert “Sahara” the highest records of coeliac disease were reported and it appeared to be 5.6%, which was almost five to ten times more frequent than that in Europe .
In the Gaza strip, the already diagnosed cases of coeliac disease have been estimated at 237 patients i.e. 0 02% of the total population in the Gaza strip .
The diagnosis of coeliac disease is classically based on clinical suspicion or atypical presentations. Compatible further many serologic markers and duodenal biopsy is the most reliable diagnostic procedure in coeliac disease.
The major complications of coeliac disease include intestinal T-cell lymphomas and extra intestinal malignancies like Non Hodgkin lymphoma and esophageal cancer. Poor dietary compliance on the long run is associated with long term complications such as chronic malnutrition, decreased blood calcium level, neurological complications, miscarriage, congenital malformations, and low birth weight of babies. Those complications are responsible for the bad prognosis of patients. It is actually improved by taking gluten free diet .
Changing lifelong eating habits and adapting new gluten free lifestyle can be a big challenge for most people with coeliac disease because gluten free diet is expensive and does not taste as good as regular foods. Hectic nutritional lifestyles may resXult in insidious intake of gluten which might be included or hidden in foods or medications that possibly contain wheat or other grains. Good dietary compliance decreases the risk for future complications and improves life of coeliac patients .
Study design and population
A cross sectional study was conducted during June 2009 on 113 children 2-18 years old diagnosed with coeliac disease in Ard El-Insan clinic in the Gaza Strip of Palestine, with a response rate of 85%. Parents, or first degree relatives, were interviewed when children 2-11 years old were unfit for responding to questionnaire .
Ethical approval and a consent form were obtained from authorized national personnel and institutions. Whilst, inclusion and exclusion criteria involved children age, diagnosis, residency, availability of age relevant caregiver, mental fitness and cooperativeness.
Study instruments of data collection
Document revision and interview questionnaires with the patient, caring parent or first degree relatives were performed to obtain information about knowledge, attitude, compliance and socio-demographic factors. Measurements of weight and height were recorded for each interviewed patient using the device Seca 700, followed with collection of 5 ml. venous blood samples in order to test blood calcium and albumin levels. Body mass index (BMI) was calculated and recorded considering the reference values of normality, underweight as <5% tiles and overweight as >85% tiles . Body weight and height were also calculated considering the child's age and cooperative attitude. Figures were recorded in kilograms to the nearest 100 grams and in centimeters to the nearest Figures are instantly recorded and double checked then the scale is recalibrated to the baseline (zero) reading. If the child is rather irritable the tarred (present in AEI clinic) weighing procedure was used instead . Children were measured for weight and height with minimal clothes, without shoes, thick socks, head covers or hair ornaments and considering the upright standing position .
Blood samples were tested for total calcium and serum albumin via “Chem-Well” blood analyzer machine.
Data analysis and processing
Data collected and admitted was analyzed using the SPSS version 13 statistical package of health information scientific analysis in order to obtain precisely accurate results. Statistical significance had been used via p value less than 0.05. Pilot study of 20 patients was conducted before starting the real data collection in order to induce necessary amendments.
Constraints of the study
The study went on smoothly despite all the inevitable constraints that had been encountering the performance in the already vulnerable Gaza Strip.
Socio-demographic factors and blood calcium level in all patients
Blood calcium level
Low range < 8.8mg/dl n=22 (%)
Normal range ≥ 8.8mg/dl n=73 (%)
Distribution of study sample by knowledge in two age groups
Life quality and cure of coeliac disease
Age group (%)
2-11Yrs n = 66 (%)
>11-18Yrs n = 29 (%)
Believe coeliac patients have a normal life
2 (6. 9)
Coeliac disease can be cured completely
Knowledge discrepancy exists between the older and younger ones whose answers were made by their mothers or care takers. This reflects an optimistic thinking appearing clearly regarding knowing life normality (p = 0.785) and curability of coeliac disease (p = 0,011) in the youngest group. This might be an attribute to an individual negative feeling rather than being a real knowledge. If their knowledge is getting better, they’ll present with more positive answers about life quality expectations and more realistic answers regarding curability.
Embarrassment being a coeliac patient and consequences
Age group (%)
2-11Yrs n = 66 (%)
>11-18Yrs n = 29 (%)
Embarrassment, if others know about patient’s or son’s sickness with CD
Whether embarrassment in front of others impair compliance to gluten free food
Behaviors denoting compliance to gluten free foods
Age group (%)
2-11Yrs n = 66 (%)
>11-18Yrs n = 29 (%)
Gluten-free foods taken outside home
Caution regarding gluten when buying food and detergent
Give special meal (Gluten free)
Body mass index distributed in study sample
Body mass index (BMI percentile)
Normal BMI (5th -85th percentile)
Underweight (< 5th percentile)
Overweight (≥ 85th percentile)
Anthropometric and biochemical indicators
Calcium and albumin blood level distributed in study sample
Albumin level in the blood
Low Albumin (<3.9g/dl)
Calcium level in the blood
Normal Calcium (8.8-10.8mg/dl)
Low Calcium l (<8.88mg/dl)
Higher Calcium (>10.8mg/dl
Controversial opinions attributable to personal attitudes and knowledge regarding health status of coeliac diseased individuals appeared when 70.3% were proved to be unhealthy despite saying that they were healthy and growing well. Such a contradiction between self and technically (clinically evidence based) evaluated ones emphasizes the fact that technical reliability is the best trend of evaluation and not to rely on patient’s or care giver’s opinion. Results were not statistically significant (P > 0.05).
Coeliac disease exists in the Gaza Strip and requires further attention by health providers. Ard El-Insan is the only organization which supports coeliac patients who are predominantly females. A questionable statistical significance exists between the blood calcium level of coeliac patients and several socio-demographic variables. To a lesser extent this could be similar to the relationship between BMI and mother education, whilst albumin level has been proved to be a sensitive indicator of noticeably low values in coeliac patients that requires higher attention.
BMI was normalized when using gluten free diet in obese or overweight patients.
High percentage of patients and mothers has contradicting ideas and notions regarding the life quality of patients with coeliac disease.
Most of patients lack the knowledge about emblem of coeliac disease. As regards knowing the gluten containing foods there had been more knowledge amongst mothers than the patients themselves especially in the older groups. Contamination of foods with gluten from different sources or food procedures inside and outside homes was poorly recognized by the patients and their care givers.
Unified knowledge pattern regarding coeliac disease is a matter of concern in many aspects relating to morbidity and mortality components as inferred from patient’s opinions regarding life quality of coeliac patients.
Feeling stigmatized by patients or their mothers was translated into embarrassment when giving their children gluten free diet outdoors or in doors.
High level of compliance towards gluten free food and medicines or detergents.
BMI, Albumin and calcium blood levels were important indicators in determining the progress of coeliac disease as linked with other etiological correlations including socio demographic elements.
Other clinical signs and symptoms of coeliac disease are important factors to judge upon the reliability of patient’s answer.
The following recommendations were considered by the researches as an outcome of this study.
More care in coeliac disease is recommended to be practiced in the primary, secondary and tertiary health care services by all health providing sectors.
Further investigations, researches and studies are necessary to facilitate building up policies for early case detection and management of coeliac disease in the Gaza Strip.
Health staff in all sectors should be encouraged, prepared and promoted in order to contribute effectively to the process of management of coeliac disease.
Encouragement of social activities and community participation of coeliac patients and their families are requested.
Development of the program in AEI and other healthy organization to support patients psychologically.
More awareness at community and institutional levels about coeliac disease.
MOH and other health sectors should be ready to offer diagnostic facilities.
More health awareness and counseling on recommended gluten free diet.
More investigation of albumin blood level in coeliac patients and follow up are required.
Screening for at risk approach individual.
The authors would sincerely acknowledge both of; Ard El-Insan Palestinian Benevolent Association for care of children in Gaza for the enormous technical and academic support during the entire period of this research work. Acknowledgement extends also to Mr. Muhannad Al-Shanti who undertook all laboratory investigations required for this work. The patients themselves and their families and care takers deserve the author’s appreciation for their absolute cooperativeness and willingness during the process of data collection. Acknowledgement goes also to Al-Azhar University and the Palestinian Ministry of Health namely, Al-Durra pediatrics hospital in Gaza for the encouragement and facilitations offered during research.
Authors' sources of funding
Authors are all self funded by their salaries gained by their own jobs and part of the research was contributed freely by Ard El-Insan Association whilst the rest was paid by the authors themselves.
- Maki M, Colin P: Coeliac disease. Nelson Textbook of Pediatrics. Edited by: Kliegman MR, Behrman ER, Jenson HB, Stanton F. 2004, Philadelphia USA, 1264-18Google Scholar
- Murray J: The widening spectrum of coeliac disease. Am J Clin Nutr. 1999, 69 (3): 354-365.PubMedGoogle Scholar
- Kagnoff MF: Overview and pathogenesis of coeliac disease. Gastroenterol. 2005, 128 (1): 10-18.View ArticleGoogle Scholar
- Detlef S: Pathogenesis of coeliac disease. Annals’ nestle. 2004, 62 (3): 96-Google Scholar
- Ludvig MS: Current understanding of the molecular and cellular basis of coeliac disease. Genetic expiration and nutrition. Nestle Nutr. 2003, 50: 167-168.Google Scholar
- Molberg O: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut derived T cells in coeliac disease. Natl Med. 1998, 4: 713-717. 10.1038/nm0698-713.View ArticleGoogle Scholar
- Labate A, Gambardell A, Mesisina D: Silent coeliac disease. Nelson Textbook of Pediatrics. Edited by: Kliegman MR, Behrman ER, Jenson HB, Stanton F. 2007, Philadelphia USA, 2415-18Google Scholar
- Feldman M, Friedman LS, Sleisenger MH, Fordtran's HS: Coeliac Disease, Gastrointestinal and liver Disease. 2003, W.B. Philadelphia Saunders, http://wiki.medpedia.com/Evidence_Report, 7,Google Scholar
- Carlsson A, Axelsson I, Borulf S: Prevalence of IgA antigliadin antibodies and IgA antiendomysium antibodies related to coeliac disease in children with Down syndrome. Pediatrics. 1998, 101: 272-275. 10.1542/peds.101.2.272.View ArticlePubMedGoogle Scholar
- Catassi C: Where is coeliac disease coming and why. J Pediatr Gastroenterol Nutr. 2005, 40 (3): 279-282. 10.1097/01.MPG.0000151650.03929.D5.View ArticlePubMedGoogle Scholar
- El-Insan A: Ard El-Insan report. 2008, Gaza: Palestinian Benevolent AssociationGoogle Scholar
- Fasano A, Catassi C: Current approaches to diagnosis and treatment of coeliac disease an evolving spectrum. Gastroenterol. 2003, 120 (3): 636-651.View ArticleGoogle Scholar
- Cureton P, Mary K: The coeliac diet, Gluten free dining out: is it safe. Pract Gastrology. 2006, 6: 61-Google Scholar
- Thabet A, Strech D, Vostanis P: Child mental health problem in Arab children: application of the strengths and difficult questionnaire. Int J Soc Psychiatry. 2004, 46: 266-280.View ArticleGoogle Scholar
- Centers for Disease Control and Prevention (CDC): Accessed, 27 Jun, 2009: Healthy weight assessing your weight: body mass index (BMI). http://www.cdc.gov/healthyweight/assessing/bmi/
- King FS, Burgess A: Growth development and nutrition for developing countries. 1992, London: Institute of Child Health, 188-2Google Scholar
- Palestinian Central Bureau of Statistical Report. 2007, Palestine: PCBSGoogle Scholar
- De schepper J, Derde MP, Goubert P, Gorus F: Reference range for laboratory test and procedures. Nelson Textbook of Pediatrics. Edited by: Kliegman MR, Behrman ER, Jenson HB, Stanton F. 2004, Philadelphia, 2415-18Google Scholar
- Anson O: Coeliac disease: parental knowledge and attitudes of dietary compliance. Pediatrics. 1990, 85 (1): 98-103.PubMedGoogle Scholar
- Cranney A, Zarkadas M, Graham I, Switzer C: The Canadian coeliac health survey the Ottawa chapter pilot. BMC Gastroenterol. 2003, 3 (8): 9-Division of Rheumatology, Department of Medicine, Queen’s University, Kingston, Ontario, CanadaGoogle Scholar
- Mohsin R: Coeliac disease: evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics. 2005, 116 (6): 754-10.1542/peds.2005-0904.View ArticleGoogle Scholar
- Cheng J, Brar PS, Lee AR, Green PH: Body mass index in coeliac disease: beneficial effect of a gluten-free diet. J Clin Gastroenterol Hepatol. 2009, 7 (9): 966-971. 10.1016/j.cgh.2009.05.028.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.